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Edited by Varda RotterAbstract When cells progressing in G1 phase are irradiated
with UV light, two damage checkpoint pathways are activated:
CHK1–Cdc25A and p53–p21WAF1/CIP1, both targeting Cdk2
but the latter inducing long lasting inactivation. In similarly irra-
diated S phase cells, however, p21WAF1/CIP1-dependent check-
point is largely inactive. We report here that p21-dependent
checkpoint can eﬀectively be activated and induce a prolonged
S phase arrest with similarly extended inactivation of Cdk2 by
association of p21 if mid-S phase cells are damaged with a
base-modifying agent instead of UV light, indicating that the
poor utilization of p21-dependent checkpoint is not an innate
property of S phase cells.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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When cells traversing G1 phase are irradiated with UV light,
the senor ATR detects damaged DNA and activates CHK1
kinase by phosphorylating at Ser345. Activated CHK1 inacti-
vates Cdc25A phosphatase. This rapid reaction causes initial
inactivation of Cdk2 resulting from accumulation of the
Tyr15 phosphorylated form. In parallel, both ATR and acti-
vated CHK1 activate and stabilize p53, which in turn induces
the cyclin-dependent kinase inhibitor p21WAF1/CIP1 that is
responsible for long lasting inactivation of Cdk2 and conse-
quently prolonged G1 arrest [1–3].
When S phase-progressing cells are similarly irradiated, the
same sensor detects damage and activates CHK1, but only
the CHK1–Cdc25A pathway is eﬃciently utilized for inactiva-
tion of Cdk2 [2,3]. Consequently, inactivation of Cdk2 is tran-
sient and S phase arrest is short although late origin ﬁring
could also be blocked via an additional mechanism involving
activated CHK1 [4]. The reason for the lack of eﬃcient utiliza-
tion of the p21-dependent system is not well understood, but it
has been attributed at least in part to poor induction of p21Abbreviations: MMS, methyl methanesulfonate; Cisplatin, cis-diamm-
inedichloroplatinum; DMEM, Dulbeccos modiﬁed Eagle medium;
MEF, mouse embryonic ﬁbroblast
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doi:10.1016/j.febslet.2007.11.075resulting from S phase-speciﬁc impairments of its transcription
and facilitation of its proteasome-mediated degradation [5–11].
We have recently found that treatment of mid-S progressing
cells with a base-modifying chemical, such as methyl methane-
sulfonate and cisplatin, eﬀectively activates p21-dependent
checkpoint and induces long lasting inactivation of Cdk2
and consequently a prolonged S phase arrest like in G1 phase,
indicating that the poor utilization of the p53–p21 pathway is
not an intrinsic property of S phase cells.2. Materials and methods
2.1. Antibodies
Methyl methanesulfonate (MMS) was purchased from Sigma; cis-
diamminedichloroplatinum (cisplatin) from WAKO. The antibodies
aCdk2 (M2), aCdk2 (M2)-G, aCyclin E (C-19), aCyclin A (C-19),
ap21 (C-19), and ap53 (Pab240) were purchased from Santa Cruz Bio-
technology; ap-Tyr15Cdc2, ap-Thr160Cdk2 and ap-CHK1 (Ser345)
from Cell Signaling; aHistone H1 from Upstate Biotechnology;
aGAPDH from Chemicon International.
2.2. Cells culture and preparation of mid-S progressing cells
Cells were maintained in Dulbeccos modiﬁed Eagle medium
(DMEM) containing 5–10% FCS. Wild-type mouse embryonic ﬁbro-
blasts were isolated from C-57 mouse embryos. The normal rat kidney
ﬁbroblast line NRK-49F and its Cdk2Y15 or Cdk2F15 overexpressers
were synchronized to mid-S phase by 16 h incubation following G0
arrest and release as described [12]. Wild-type and p21/ mouse
embryonic ﬁbroblasts [13] were synchronized to early S by a double
thymidine block [14] and cultured in fresh medium for 1–2 h to pro-
gress into mid-S phase.2.3. DNA damage with chemicals and UV irradiation
Cells traversing mid-S phase (2–5 · 105 in a 10 cm dish for each time
point) were treated for 2–3 h with 120–150 lg/ml methyl methanesulfo-
nate (MMS), 4 h with 20 lg/ml cisplatin contained in growth medium
or irradiated with UV light at 7.5 J/m2, washed twice with phosphate-
buﬀered saline, and cultured in growth medium containing 25 ng/ml
colcemid with cell sampling at the speciﬁed times.2.4. Cytometric analysis
Flow cytometric analysis was performed with the FACScan ﬂow
cytometer (BECKMAN COULTER ECPIS XL) equipped with com-
puter-assisted analysis of cell population in each cell cycle phase
according to the manufacturers instruction.2.5. Preparation of whole cell lysates, Cdk2 kinase assay and
immunoblot
Harvested cells were lysed with ice-cold immunoprecipitation buﬀer
containing 0.35 M NaCl. One half of the lysates was used for detection
of the speciﬁed proteins by immunoblot and the other half for assay of
Cdk2 activity and associated proteins as described [15].blished by Elsevier B.V. All rights reserved.
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3.1. Treatment of mid-S phase-progressing cells with methyl
methanesulfonate induces a long-lasting S phase arrest with
inactivation of Cdk2
During studies on DNA damage-induced arrest and recov-
ery of S phase-progressing cells, we observed that treatment of
mid-S progressing rat ﬁbroblast line NRK-49F [12] with a
comparable dose of methyl methanesulfonate (MMS) but
not of UV irradiation led to a prolonged S phase arrest
accompanied by similarly extended inactivation of Cdk2 with
binding of p21 despite that the same sensor ATR was known
to detect both damages [2]. In this experiment, mid-S pro-
gressing NRK cells were treated for 3 h with MMS at
120 lg/ml or irradiated with UV light at 7.5 J/m2 and cultured
further in growth medium containing colcemid, a metaphase
blocker, to prevent their return to G1 that could obscure the
population of S phase-arrested cells. During MMS treatment
and subsequent culturing, cells were collected every 4 h and
analyzed for cell viability, cell cycle patterns and the levels
of CHK1 and its Ser345 phosphorylated active form, Cdc25A,
p21, p53, Cdk2 activity, Cdk2, its Tyr15 phosphorylated form
and associated p21 by immunoblot, immunoprecipitation and
kinase assay. The viability of these cells was 70–80% as as-
sayed by colony forming ability, indicating that the extent
of the damage induced by both treatments was comparable.
In this series of experiment, mock-treated cells rapidly tra-
versed S phase and reached G2/M phase within 2–4 h (data
not shown).
Cytometric analysis with computational estimation of cell
population in each cell cycle phase revealed that the MMS-
treated cells arrested in S phase for at least 20 h (Fig. 1A left
upper panel). In response to MMS, Ser345 phosphorylation
of CHK1 was detected at 4 h and disappeared by 8 h. The on-
set of CHK1 phosphorylation was followed by induction of
p53 and p21 with concomitant inactivation of Cdk2, which
persisted for at least 20 h. As indicated by a sudden increase
of G2/M cells with a proportional decrease of S phase cells,
recovery from S phase arrest began by 24 h. During arrest,
Cdk2 underwent no apparent Tyr15 phosphorylation but asso-
ciation with signiﬁcant amounts of p21, which diminished at
the time of its re-activation.
By contrast, the UV-irradiated NRK cells arrested for less
than 12 h accompanied by inactivation of Cdk2 with no
apparent binding of p21 but an elevation of Tyr15 phosphor-
ylation at 4–8 h with a slight decrease of Cdc25A protein
although the extents of CHK1 phosphorylation and p21 induc-
tion were very similar between the two treatments (Fig. 1A
right panels). Furthermore, re-activation of Cdk2 coincided
roughly with the diminishment of Tyr15 phosphorylation to
the original level that occurred at 12 h. These results conﬁrm
the well established ﬁnding that Cdc25A-dependent check-
point is predominantly utilized in S phase upon UV damage
and reveal that MMS treatment induces a prolonged S phase
arrest accompanied by a similarly extended inactivation of
Cdk2 with binding of p21 but no apparent elevation in
Tyr15 phosphorylation.
MMS is not the only chemical that can induce a prolonged S
phase arrest with inactive Cdk2 bound by p21. When treated
with cis-diamminedichloroplatinum (cisplatin), another fre-
quently used DNA base-modifying agent [16], mid-S progress-
ing NRK cells similarly underwent an extended arrest for morethan 16 h, again accompanied by inactivation of Cdk2 with
p21 binding but no obvious elevation of Tyr15 phosphoryla-
tion, long after the Ser345 phosphorylation of CHK1 disap-
peared (Fig. 1B).3.2. MMS treatment induces long lasting S phase arrest to
primary mouse embryonic ﬁbroblasts
Similarly, NRK is not the only cell that responds MMS and
arrests long in S phase with extended inactivation of Cdk2 with
binding of p21. When wild-type mouse embryonic ﬁbroblasts
(MEF) traversing mid-S phase were treated with MMS and
cultured further, they arrested for more than 20 h with con-
comitant inactivation of Cdk2, just like NRK cells (Fig. 2 left
panel). During the prolonged arrest, Tyr15 phosphorylation of
Cdk2 did not elevate whereas induced p21 bound the inactive
Cdk2. Furthermore, there were no signiﬁcant changes in the
amounts of Cdk2-associated cyclins A and E or in the level
of Thr160 phosphorylation that was essential for activation
of this kinase. Prolonged S phase arrest with Cdk2 inactivation
was observed also with MMS-treated mouse ﬁbroblast line
C3H10T1/2 (data not shown).3.3. p21WAF1 but not tyrosine phosphorylation is responsible for
the inactivation of Cdk2 during MMS-induced extended S
phase arrest
The critical involvement of p21 in MMS-induced long last-
ing Cdk2 inactivation and S phase arrest was established by
analysis of p21/ mouse embryonic ﬁbroblasts (p21/
MEF). When mid-S progressing p21/ MEF [15] was treated
with MMS and analyzed just like for wild-type MEF, its S
phase arrest was short (<12 h) and Cdk2 remained active de-
spite that CHK1 was similarly activated (Fig. 2 right panel).
By contrast, there was no noticeable involvement of
Cdc25A-dependent checkpoint in the extended inactivation
of Cdk2 that was induced by MMS treatment. When two
NRK cell clones both 4–5-folds overexpressing wild type
Cdk2 (Cdk2Y15) and unphosphorylatable Cdk2F15, respec-
tively, were treated with MMS during their mid-S progression
and similarly analyzed, both of them arrested in S phase for
roughly the same duration with inactive Cdk2 bound by p21
(Fig. 3). During the arrest, the level of Tyr15 phosphoryla-
tion of wild-type Cdk2 elevated slightly after 2 h whereas
the onset of inactivation of Cdk2F15 delayed about 2 h, sug-
gesting that Cdc25A-dependent checkpoint was also activated
albeit very weakly and participated in the initial phase of
Cdk2 inactivation upon MMS treatment. Like in Fig. 1A,
reactivation of Cdk2 roughly coincided with a reduction of
bound p21.3.4. Subcellular localization of induced p21 is similar between
MMS treatment and UV irradiation
As shown above, unlike UV irradiation, MMS treatment
let induced p21 to bind and inactivate Cdk2 despite the same
level of induction. But this was not made by changes in
subcellular localization of induced p21 or Cdk2. The same
experiment as in Fig. 1A was carried out with additional
comparison of the amounts of cytosolic and nuclear/chroma-
tin-bound p21 as well as Cdk2 between MMS- and UV-trea-
ted cells. As shown in Fig. 4, despite the preferential
association of induced p21 with the Cdk2 only in MMS-trea-
Fig. 1. Treatment of mid-S phase-progressing cells with a base-modifying agent induces long lasting S phase arrest with closely associated p21
induction and Cdk2 inactivation. (A) MMS treatment induces prolonged S phase arrest with binding of p21 to the inactive Cdk2. Mid S-progressing
NRK cells were treated for 3 h with MMS at 120 lg/ml contained in growth medium or irradiated with UV light at 7.5 J/m2, and incubated in
colcemid-containing culture medium with every 4 h cell sampling (the start of treatment as 0 h). Their cytometric patterns and calculated cell
population in each phase are shown. In parallel, each cell sample was analyzed for the levels of CHK1, CHK1 phosphorylated at S345 (pCHK1),
Cdc25A, p21, p53 and Cdk2 as well as determined for the levels of Cdk2 activity, Cdk2, its Tyr15 phosphorylation (pCdk2Y15) and associated p21
after immunoprecipitation of Cdk2. b-Actin was used as loading control. (B) Treatment with cisplatin similarly induces an extended S phase arrest
with inactive Cdk2 bound by p21. Mid S-progressing NRK cells were treated for 4 h with cisplatin at 20 lg/ml in growth medium, cultured in
colcemid-containing growth medium with cell sampling and analyzed as in A.
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levels of p21 or Cdk2 contained in the cytoplasmic and nucle-ar/chromatin-bound fractions between MMS-treated and UV-
irradiated cells.
Fig. 2. p21WAF1/CIP1 is responsible for MMS-induced Cdk2 inactivation. Mid-S progressing wild-type and p21/ MEFs [13] were treated for 3 h
with 150 lg/ml MMS and incubated in colcemid-containing culture medium with cell sampling. Collected cells were analyzed for cell cycle patterns,
the levels of pCHK1, CHK1, p53, p21, Cdk2 activity and amount, its phosphorylation states (Tyr15 and Thr160 phosphorylation: pCdk2Y15 and
pCdk2T160) and associated cyclins and p21.
Fig. 3. Interruption of Cdc25A-dependent checkpoint does not aﬀect the prolonged S phase arrest induced with MMS. Two NRK clones [12] each 4–
5-fold overexpressing wild-type Cdk2 or mutant Cdk2F15 in which Tyr15 is substituted by unphosphorylatable phenylalanine were synchronized to
mid-S phase, treated with MMS as in Fig. 1 and analyzed for cell cycle patterns and for the activity and amount of Cdk2, its phosphorylation states
and the amounts of Cdk2-associated cyclins and p21.
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One strange property of S phase-progressing cells is that de-
spite activation/induction of p53, the p53–p21 pathway is not
eﬀectively utilized to inactivate Cdk2 when cells are challenged
with ionizing radiation or UV light [2,3]. Consequently, inacti-
vation of Cdk2 is transient and S phase arrest is short.Although the mechanistic basis for the lack of eﬀective utiliza-
tion of the p53–p21 pathway in S phase cells is not well under-
stood, it has been attributed at least in part to the relatively
poor induction of p21 that is resulted from S phase-speciﬁc
impairments in transcription of the p21 gene and its protea-
some-mediated destabilization [5–8,11]. Therefore, it would
not be unreasonable to speculate that poor utilization of
Fig. 4. Subcellular localization of induced p21 and Cdk2 is indistinguishable between MMS treatment and UV irradiation. Mid-S phase-
synchronized NRK cells were treated with MMS or UV and analyzed as in Fig. 1A. (Lower panel) The cytosolic (C) and nuclear/chromatin-bound
(N) fractions were prepared by digitonin-mediated cell permeabilization [17] and subsequent 0.35 M NaCl/immunoprecipitation buﬀer extraction of
each cell sample and immunoblotted for p21, Cdk2, Histone H1 (H1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the latter two as
nuclear and cytoplasmic markers, respectively.
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property of S phase cells and could potentially beneﬁt them
because unlike in G1/S, prolonged arrest in S phase might
severely harm cells as a consequence of a possible collapse dur-
ing the arrest of all the replication machineries that have been
established and functioning by the time of DNA damage. Con-
sistent with this notion is the ﬁnding that DNA repair and
recovery from arrest are facilitated by the low level mainte-
nance of p21 by proteolytic degradation when cells were dam-
aged with UV light [9,10].
However, this is unlikely to be the case. As presented here,
the p53–p21 pathway can be utilized eﬀectively at least in
mid-S phase cells when treated with a base-modifying chemical.
Its consequence is a p21-dependent extended S phase arrest and
inactivation of Cdk2. Despite suﬀering a nearly 24 h arrest in
mid-S phase, the MMS-treated NRK cells still recovered and
re-initiated cell cycle progression (Fig. 1A), retaining roughly
70% viability as assayed by colony formation capability.
One important question raised by the current study is: How
could MMS treatment activate p21-dependent checkpoint in S
phase cells? As we showed, there was a marked diﬀerence in the
amount of Cdk2-bound p21 between MMS treatment and UV
irradiation, and readily detectable amounts of p21 were associ-
ated with inactive Cdk2 in MMS-treated cells but not in UV-
irradiated cells. However, there was no signiﬁcant diﬀerence in
either the level of induced p21 or its subcellular localization be-tween the two treatments (Figs. 1A and 4). Thus, neither poor
induction of p21 nor possible sequestration of p21 via forced
changes in subcellular localization is likely to be the critical
determinant of the ineﬀective utilization of p21-dependent
checkpoint in UV-irradiated S phase cells.Acknowledgements: We thank E. Hara for p21/ MEF. This work
was supported by grants from Ministry of Education, Science and Cul-
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